aap Implantate AG

XETRA AAQ1.DE

aap Implantate AG Operating Cash Flow for the year ending December 31, 2023: USD -3.30 M

aap Implantate AG Operating Cash Flow is USD -3.30 M for the year ending December 31, 2023, a -63.05% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

aap Implantate AG Operating Cash Flow for the year ending December 31, 2022 was USD -2.03 M, a 27.97% change year over year.
aap Implantate AG Operating Cash Flow for the year ending December 31, 2021 was USD -2.81 M, a 37.37% change year over year.
aap Implantate AG Operating Cash Flow for the year ending December 31, 2020 was USD -4.49 M, a 30.63% change year over year.
aap Implantate AG Operating Cash Flow for the year ending December 31, 2019 was USD -6.47 M, a 4.46% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

XETRA: AAQ1.DE

aap Implantate AG

CEO	Mr. Rubino Di Girolamo
IPO Date	May 11, 1999
Location	Germany
Headquarters	Lorenzweg 5
Employees	87
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Composite Materials Glass Hardware & Electronics Pharmaceuticals Plastics

Description

aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Key trends

Past 5 years